LUND, Sweden--(BUSINESS WIRE)--Regulatory News: Probi (STO:PROB) and Pharmavite have signed a new long-term agreement for distribution and marketing of Probi’s probiotic products. Under the new agreement Pharmavite will broaden the distribution and expand the Nature Made® range with additional probiotic products from Probi. Pharmavite will also expand it´s probiotic business internationally, among other markets, in the Middle East.
Help employers find you! Check out all the jobs and post your resume.
